Palantir Shorts Rebuild Ahead of Q3 Results

Palantir Technologies enters its November 2 earnings with short sellers rebuilding positions at a measured but steady pace, even as the stock added 3.2% on the week to close at $198.73, lagging a peer group whose median gain ran to 7.3%.

Short interest has climbed for seven consecutive sessions, reaching 2.6% of the free float from a recent low around 2.3%, a 5.8% increase over the week and the highest level in roughly five weeks. The FINRA fortnightly count confirms 56.1 million shares short as of October 15, with the daily estimate now tracking above that at 59.3 million. The rebuild is gradual rather than aggressive: at roughly 2.6% of float, the absolute level remains well below the 66 to 67 million shares that were short in mid-September, and borrow conditions are completely unremarkable. Availability is running at nearly 9,000% of short interest, one of the loosest borrow pools in the market, meaning there is no structural constraint on new shorts or any squeeze mechanism at work. Cost to borrow fell sharply to 0.15% on October 27 from 0.46% the prior session, unwinding most of the modest tightening seen through the middle of the month. The ORTEX short score has ticked up to 31.6 from 30.9 two weeks ago, a gentle drift rather than a directional signal.

Options positioning tells a more cautious story. The put/call ratio is at 1.15, about 1.5 standard deviations above its 20-day average of 1.10, and close to the highest reading of the past 52 weeks at 1.16. The ratio has been drifting higher since late September, when it ran near 1.04. That steady accumulation of put protection over call exposure is the more meaningful signal in the positioning data right now: it is not a single-session spike but a sustained shift as the earnings date has approached.

Analyst activity has been uniformly constructive over the past month, which creates a visible contrast with the defensive options posture. Citi raised its target to $250 from $245 on October 22. Mizuho lifted its target to $245 from $215 on October 15. Barclays initiated coverage at Overweight with a $265 target on October 9. Goldman Sachs upgraded the stock to Buy on October 8, assigning a $230 target. The direction of travel across the Street is unambiguously positive. Yet the consensus rating remains Hold and the mean target sits around $185, below the current price of $198.73, reflecting a broader cohort that has not moved as quickly as the recent crop of raises. The valuation backdrop is demanding: the trailing PE is around 90x and EV/EBITDA is roughly 64x, though both have eased slightly over the past month. EPS momentum ranks in the 85th and 87th percentile over 30 and 90 days respectively, which is the quality underpinning the bull case. The bear case centres on government spending concentration, founder voting control at nearly 50%, and the risk that competition from Microsoft, Amazon, and Snowflake compresses pricing as commercial deployments scale beyond bootcamp conversions.

Insider activity warrants a note of context. Director Alexander Moore sold a combined 16,000 shares across multiple tranches on October 15, totalling roughly $3.2 million. Director Eric Woersching sold 1,000 shares on October 9, and Director Lauren Friedman Stat sold approximately 5,000 shares on October 8 for just over $1 million. Every transaction was executed under a pre-arranged 10b5-1 trading plan, which means each sale was scheduled in advance at a set price, rather than a discretionary response to the current price level. Net insider activity over the past 90 days runs to minus 605,000 shares, worth roughly $106 million. That figure is large in dollar terms but almost entirely attributable to planned programme selling at a stock trading near its all-time high, which is a structurally different signal from discretionary disposal.

Palantir's prior quarterly result, reported August 3, produced a one-day gain of 32% and a five-day gain of 42%. That print was accompanied by commercial revenue growth of 110% and net revenue retention of 186%. The November 2 report arrives with the stock up roughly 3% on the week but trailing peers including Rubrik, which gained 18% this week, and Rapid7, which added 33%. The relative underperformance alongside rebuilding short interest, elevated put/call ratios, and a mean analyst target below the current price frames the question for next Monday's close: whether the results replicate the August setup or confirm that the stock has run ahead of what the next print can justify.